• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Treatments in the COVID-19 pandemic: an update on clinical trials.2019冠状病毒病大流行中的治疗方法：临床试验最新情况
Expert Opin Emerg Drugs. 2020 Jun;25(2):81-88. doi: 10.1080/14728214.2020.1773431. Epub 2020 Jun 17.
2
COVID-19: An Update on Clinical Trials.新型冠状病毒肺炎：临床试验最新进展
Curr Top Med Chem. 2020;20(17):1516-1517. doi: 10.2174/1568026620999200511092332.
3
Clinical trials: Management of investigational products during the COVID-19 pandemic.临床试验：COVID-19 大流行期间试验产品的管理。
Am J Health Syst Pharm. 2020 Aug 7;77(16):1277-1278. doi: 10.1093/ajhp/zxaa146.
4
World War against COVID-19: How strong is our armamentarium?抗击新冠疫情之战：我们的武器库有多强大？
Med J Malaysia. 2020 May;75(3):314-315.
5
COVID-19 pandemic: what can pharmaceutical formulation and drug delivery experts offer?新冠疫情：药物制剂与药物递送专家能提供什么？
Pharm Dev Technol. 2020 Jul;25(6):649. doi: 10.1080/10837450.2020.1764670.
6
Favipiravir, an antiviral for COVID-19?法匹拉韦，一种用于治疗新冠肺炎的抗病毒药物？
J Antimicrob Chemother. 2020 Jul 1;75(7):2013-2014. doi: 10.1093/jac/dkaa171.
7
Effective Chemicals against Novel Coronavirus (COVID-19) in China.中国针对新型冠状病毒（COVID-19）的有效化学品。
Curr Top Med Chem. 2020;20(8):603-605. doi: 10.2174/1568026620999200305145032.
8
A Call for Pediatric COVID-19 Clinical Trials.呼吁开展儿童 COVID-19 临床试验。
Pediatrics. 2020 Aug;146(2). doi: 10.1542/peds.2020-1081. Epub 2020 May 12.
9
Potential pharmacological agents for COVID-19.用于治疗 COVID-19 的潜在药物。
Indian J Public Health. 2020 Jun;64(Supplement):S112-S116. doi: 10.4103/ijph.IJPH_456_20.
10
Rapid repurposing of drugs for COVID-19.用于治疗新冠肺炎的药物快速重新利用。
Science. 2020 May 22;368(6493):829-830. doi: 10.1126/science.abb9332. Epub 2020 May 8.

引用本文的文献

1
Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options.新冠病毒病中的内皮功能障碍：潜在机制与可能的治疗选择
Life (Basel). 2022 Oct 14;12(10):1605. doi: 10.3390/life12101605.
2
COVID-19: Pulmonary and Extra Pulmonary Manifestations.新型冠状病毒肺炎：肺及肺外表现。
Front Public Health. 2021 Sep 28;9:711616. doi: 10.3389/fpubh.2021.711616. eCollection 2021.
3
Regioselective Mercury(I)/Palladium(II)-Catalyzed Single-Step Approach for the Synthesis of Imines and 2-Substituted Indoles.汞（I）/钯（II）催化的区域选择性单步法合成亚胺和 2-取代吲哚。
Molecules. 2021 Jul 5;26(13):4092. doi: 10.3390/molecules26134092.
4
Unraveling the unbinding pathways of SARS-CoV-2 Papain-like proteinase known inhibitors by Supervised Molecular Dynamics simulation.通过有监督的分子动力学模拟揭示 SARS-CoV-2 木瓜蛋白酶样蛋白酶已知抑制剂的解结合途径。
PLoS One. 2021 May 19;16(5):e0251910. doi: 10.1371/journal.pone.0251910. eCollection 2021.
5
Role of arachidonic cascade in COVID-19 infection: A review.花生四烯酸级联在 COVID-19 感染中的作用：综述。
Prostaglandins Other Lipid Mediat. 2021 Jun;154:106539. doi: 10.1016/j.prostaglandins.2021.106539. Epub 2021 Feb 14.
6
COVID-19 vaccines: The status and perspectives in delivery points of view.COVID-19 疫苗：交付观点中的现状和展望。
Adv Drug Deliv Rev. 2021 Mar;170:1-25. doi: 10.1016/j.addr.2020.12.011. Epub 2020 Dec 24.
7
Extrapulmonary Clinical Manifestations in COVID-19 Patients.新冠肺炎患者的肺外临床表现。
Am J Trop Med Hyg. 2020 Nov;103(5):1783-1796. doi: 10.4269/ajtmh.20-0986.
8
Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: An updated review until June 2020.当前冠状病毒（SARS-CoV-2）的流行病学、诊断和治疗方法：截至2020年6月的最新综述
EXCLI J. 2020 Jul 20;19:992-1016. doi: 10.17179/excli2020-2554. eCollection 2020.
9
Recent Advancements in the Diagnosis, Prevention, and Prospective Drug Therapy of COVID-19.COVID-19 的诊断、预防和潜在药物治疗的最新进展。
Front Public Health. 2020 Jul 10;8:384. doi: 10.3389/fpubh.2020.00384. eCollection 2020.

本文引用的文献

1
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.致病性T细胞和炎性单核细胞在重症COVID-19患者中引发炎症风暴。
Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.
2
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
3
Tocilizumab in COVID-19: Beware the risk of intestinal perforation.托珠单抗治疗新型冠状病毒肺炎：谨防肠穿孔风险。
Int J Antimicrob Agents. 2020 Jul;56(1):106009. doi: 10.1016/j.ijantimicag.2020.106009. Epub 2020 May 7.
4
Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients.托珠单抗治疗可降低 COVID-19 患者的重症监护病房入院率和/或死亡率。
Med Mal Infect. 2020 Aug;50(5):397-400. doi: 10.1016/j.medmal.2020.05.001. Epub 2020 May 6.
5
Convalescent plasma in Covid-19: Possible mechanisms of action.恢复期血浆治疗 COVID-19：可能的作用机制。
Autoimmun Rev. 2020 Jul;19(7):102554. doi: 10.1016/j.autrev.2020.102554. Epub 2020 May 5.
6
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.托珠单抗治疗伴有炎症过度反应和急性呼吸衰竭的重症 COVID-19 肺炎：意大利布雷西亚单中心 100 例患者研究。
Autoimmun Rev. 2020 Jul;19(7):102568. doi: 10.1016/j.autrev.2020.102568. Epub 2020 May 3.
7
Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?托珠单抗治疗新型冠状病毒肺炎细胞因子风暴综合征：念珠菌血症风险增加？
Autoimmun Rev. 2020 Jul;19(7):102564. doi: 10.1016/j.autrev.2020.102564. Epub 2020 May 5.
8
The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro.抗流感病毒药物阿比朵尔在体外是严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的有效抑制剂。
Cell Discov. 2020 May 2;6:28. doi: 10.1038/s41421-020-0169-8. eCollection 2020.
9
Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol.COVID-19 药物治疗的心脏安全性：综述及建议监测方案。
Eur Heart J Acute Cardiovasc Care. 2020 Apr;9(3):215-221. doi: 10.1177/2048872620922784. Epub 2020 May 6.
10
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19).综述：羟氯喹啉和氯喹啉用于治疗严重急性呼吸综合征冠状病毒2（COVID-19）
Open Forum Infect Dis. 2020 Apr 15;7(4):ofaa130. doi: 10.1093/ofid/ofaa130. eCollection 2020 Apr.

Treatments in the COVID-19 pandemic: an update on clinical trials.

作者信息

Tao Yanyi, Tang Liang V, Hu Yu

机构信息

Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, China.

出版信息

Expert Opin Emerg Drugs. 2020 Jun;25(2):81-88. doi: 10.1080/14728214.2020.1773431. Epub 2020 Jun 17.

DOI:10.1080/14728214.2020.1773431
PMID:32447996
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7441772/
Abstract
摘要